Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.84)
# 410
Out of 4,520 analysts
366
Total ratings
49.1%
Success rate
25%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Maintained: Buy | $48 | $14.86 | +223.01% | 9 | Jul 16, 2026 | |
| PTCT PTC Therapeutics | Rated: Buy | $124 → $130 | $78.52 | +65.56% | 23 | Jul 15, 2026 | |
| SUPN Supernus Pharmaceuticals | Maintained: Buy | $63 → $67 | $48.21 | +38.98% | 10 | Jul 9, 2026 | |
| CAPR Capricor Therapeutics | Maintained: Buy | $62 | $19.12 | +224.27% | 14 | Jul 6, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $11 | $3.94 | +179.19% | 5 | Jun 25, 2026 | |
| STO: EGTX Egetis Therapeutics AB (publ) | Initiated Coverage: Buy | kr 23.00 | kr 6.26 | +267.41% | 1 | Jun 25, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | $26.67 | $8.68 | +207.28% | 9 | Jun 24, 2026 | |
| RNA Atrium Therapeutics | Initiated Coverage: Buy | $25 | $12.16 | +105.59% | 1 | Jun 18, 2026 | |
| QURE uniQure | Upgraded: Buy | n/a | $39.36 | - | 12 | Jun 17, 2026 | |
| CDXS Codexis | Maintained: Buy | $11 | $2.16 | +409.26% | 10 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $35.40 | +89.27% | 25 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $34 | $12.76 | +166.46% | 9 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 → $96 | $30.22 | +217.67% | 15 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $109 | $108.52 | +0.44% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.05 | +76.80% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3228 | +829.37% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $73.47 | +70.14% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.33 | +92.08% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.56 | +316.67% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $8.81 | +240.52% | 12 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $5.97 | +218.26% | 19 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $24 | $3.50 | +585.71% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $21 | $17.23 | +21.88% | 27 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.6286 | +218.17% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $41.67 | -8.81% | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $7.02 | +298.86% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $10.97 | +164.36% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.83 | +265.54% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $0.6596 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.28 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.17 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $1.46 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $11.88 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $0.89 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $30.24 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.52 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 → $28 | $0.0555 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.207 | n/a | 4 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.25 → $10 | $1.35 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $0.5501 | n/a | 2 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $7.12 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.37 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.6445 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0012 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.5848 | n/a | 1 | Nov 30, 2020 |
DBV Technologies
Jul 16, 2026
Maintained: Buy
Price Target: $48
Current: $14.86
Upside: +223.01%
PTC Therapeutics
Jul 15, 2026
Rated: Buy
Price Target: $124 → $130
Current: $78.52
Upside: +65.56%
Supernus Pharmaceuticals
Jul 9, 2026
Maintained: Buy
Price Target: $63 → $67
Current: $48.21
Upside: +38.98%
Capricor Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $62
Current: $19.12
Upside: +224.27%
Aquestive Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $11
Current: $3.94
Upside: +179.19%
Egetis Therapeutics AB (publ)
Jun 25, 2026
Initiated Coverage: Buy
Price Target: kr 23.00
Current: kr 6.26
Upside: +267.41%
Eupraxia Pharmaceuticals Inc.
Jun 24, 2026
Maintained: Buy
Price Target: $26.67
Current: $8.68
Upside: +207.28%
Atrium Therapeutics
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $12.16
Upside: +105.59%
uniQure
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $39.36
Upside: -
Codexis
Jun 16, 2026
Maintained: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Jun 14, 2026
Maintained: Buy
Price Target: $67
Current: $35.40
Upside: +89.27%
Jun 8, 2026
Maintained: Buy
Price Target: $24 → $34
Current: $12.76
Upside: +166.46%
May 20, 2026
Rated: Buy
Price Target: $84 → $96
Current: $30.22
Upside: +217.67%
May 14, 2026
Maintained: Buy
Price Target: $109
Current: $108.52
Upside: +0.44%
May 12, 2026
Maintained: Buy
Price Target: $16
Current: $9.05
Upside: +76.80%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3228
Upside: +829.37%
May 12, 2026
Maintained: Buy
Price Target: $125
Current: $73.47
Upside: +70.14%
Apr 30, 2026
Maintained: Buy
Price Target: $16
Current: $8.33
Upside: +92.08%
Mar 30, 2026
Maintained: Buy
Price Target: $19
Current: $4.56
Upside: +316.67%
Mar 25, 2026
Downgraded: Hold
Price Target: $30
Current: $8.81
Upside: +240.52%
Mar 24, 2026
Maintained: Buy
Price Target: $19
Current: $5.97
Upside: +218.26%
Mar 19, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $3.50
Upside: +585.71%
Mar 16, 2026
Maintained: Hold
Price Target: $14 → $21
Current: $17.23
Upside: +21.88%
Mar 10, 2026
Maintained: Hold
Price Target: $2
Current: $0.6286
Upside: +218.17%
Mar 3, 2026
Maintained: Hold
Price Target: $38
Current: $41.67
Upside: -8.81%
Feb 23, 2026
Maintained: Buy
Price Target: $28
Current: $7.02
Upside: +298.86%
Jan 13, 2026
Maintained: Buy
Price Target: $29
Current: $10.97
Upside: +164.36%
Nov 21, 2025
Maintained: Buy
Price Target: $14
Current: $3.83
Upside: +265.54%
Jul 1, 2024
Maintained: Buy
Price Target: $6 → $7
Current: $0.6596
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $3.28
Upside: n/a
Feb 4, 2024
Maintained: Buy
Price Target: $6
Current: $1.17
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $1.46
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $11.88
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $27
Current: $0.89
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $30.24
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.52
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $3.5 → $28
Current: $0.0555
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.207
Upside: n/a
Dec 21, 2022
Maintained: Hold
Price Target: $4.25 → $10
Current: $1.35
Upside: n/a
Aug 4, 2022
Downgraded: Hold
Price Target: $14 → $11
Current: $0.5501
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $7.12
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.37
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $10
Current: $0.6445
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0012
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.5848
Upside: n/a